clinical trials

A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for Prevention of COVID-19 Infection

This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent infection with COVID-19. The study will last 24 weeks.

A Study of Quintuple Therapy to Treat COVID-19 Infection (HAZCpaC) 

This Phase II interventional study will test the efficacy of quintuple therapy in the treatment of patients with COVID-19 infection). The study will last 24 weeks.

A Study of ResCure™ to Treat COVID-19 Infection 

This is a Phase I open-label interventional study which will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection.

Trial of Combination Therapy to Treat COVID-19 Infection

In this trial patients will be treated with either a combination of therapies (Ivermectin, Doxycycline Hcl, Zinc, Vitamin D3, Vitamin C) to treat COVID-19 or a placebo. Treatment will last 10 days, and patients will be followed for 6 months.

A Study of Combination Therapies to Treat COVID-19 Infection

This study seeks to determine whether dual therapy or quadruple therapy is more effective in treating COVID-19.

A Study of Quintuple Therapy to Treat COVID-19 Infection (HAZCpaC)

This Phase II interventional study will test the efficacy of quintuple therapy (Hydroxychloroquine, Azithromycin, Vitamin C, Vitamin D, and Zinc) in the treatment of patients with COVID-19 infection). The study will last 24 weeks.